AbbVie (ABBV) is a publicly traded Healthcare sector company. As of October 18, 2026, ABBV trades at $285.72 with a market cap of $504.37B and a P/E ratio of 76.58. ABBV moved +1.23% today. Year to date, ABBV is +24.92%; over the trailing twelve months it is +25.81%. Its 52-week range spans $164.39 to $291.40. Analyst consensus is strong buy with an average price target of $286.67. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AbbVie (ABBV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABBV moved +1.23% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $285.72 |
| Market Cap | $504.37B |
| P/E Ratio | 76.58 |
| EPS | $3.54 |
| Dividend Yield | 1.73% |
| 52-Week High | $291.40 |
| 52-Week Low | $164.39 |
| Volume | 3.93M |
| Avg Volume | 0 |
| Revenue (TTM) | $64.39B |
| Net Income | $6.32B |
| Gross Margin | 71.48% |
24 analysts cover ABBV: 0 strong buy, 20 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $286.67.